Product NDC: | 0093-5206 |
Proprietary Name: | OXYBUTYNIN CHLORIDE |
Non Proprietary Name: | OXYBUTYNIN CHLORIDE |
Active Ingredient(s): | 5 mg/1 & nbsp; OXYBUTYNIN CHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-5206 |
Labeler Name: | TEVA Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076745 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070511 |
Package NDC: | 0093-5206-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5206-01) |
NDC Code | 0093-5206-01 |
Proprietary Name | OXYBUTYNIN CHLORIDE |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5206-01) |
Product NDC | 0093-5206 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | OXYBUTYNIN CHLORIDE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20070511 |
Marketing Category Name | ANDA |
Labeler Name | TEVA Pharmaceuticals USA Inc |
Substance Name | OXYBUTYNIN CHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |